| Towards tuberculosis elimination: an action framework for low-incidence countries K Lönnroth, GB Migliori, I Abubakar, L D'Ambrosio, G De Vries, R Diel, ... European Respiratory Journal 45 (4), 928-952, 2015 | 870 | 2015 |
| Infection of human macrophages and dendritic cells with Mycobacterium tuberculosis induces a differential cytokine gene expression that modulates T cell response E Giacomini, E Iona, L Ferroni, M Miettinen, L Fattorini, G Orefici, ... The Journal of Immunology 166 (12), 7033-7041, 2001 | 621 | 2001 |
| Mycobacterium tuberculosis Strains with Highly Discordant Rifampin Susceptibility Test Results A Van Deun, L Barrera, I Bastian, L Fattorini, H Hoffmann, KM Kam, ... Journal of clinical microbiology 47 (11), 3501-3506, 2009 | 249 | 2009 |
| rpoB Mutations in Multidrug-Resistant Strains of Mycobacterium tuberculosis Isolated in Italy G Pozzi, M Meloni, E Iona, G Orrù, OF Thoresen, ML Ricci, MR Oggioni, ... Journal of clinical microbiology 37 (4), 1197-1199, 1999 | 166 | 1999 |
| Whole genome sequencing reveals complex evolution patterns of multidrug-resistant Mycobacterium tuberculosis Beijing strains in patients M Merker, TA Kohl, A Roetzer, L Truebe, E Richter, S Rüsch-Gerdes, ... PloS one 8 (12), e82551, 2013 | 159 | 2013 |
| Transcription and expression analysis, using lacZ and phoA gene fusions, of Mycobacterium fortuitumβ‐lactamase genes cloned from a natural isolate and a high … J Timm, MG Perilli, C Duez, J Trias, G Orefici, L Fattorini, G Amicosante, ... Molecular microbiology 12 (3), 491-504, 1994 | 129 | 1994 |
| Mycobacterium tuberculosis subverts the differentiation of human monocytes into dendritic cells S Mariotti, R Teloni, E Iona, L Fattorini, F Giannoni, G Romagnoli, ... European journal of immunology 32 (11), 3050-3058, 2002 | 126 | 2002 |
| The Extra Cytoplasmic Function Sigma Factor σE Is Essential for Mycobacterium tuberculosis Virulence in Mice R Manganelli, L Fattorini, D Tan, E Iona, G Orefici, G Altavilla, P Cusatelli, ... Infection and immunity 72 (5), 3038-3041, 2004 | 115 | 2004 |
| Rifampin induces hydroxyl radical formation in Mycobacterium tuberculosis G Piccaro, D Pietraforte, F Giannoni, A Mustazzolu, L Fattorini Antimicrobial agents and chemotherapy 58 (12), 7527-7533, 2014 | 103 | 2014 |
| Bacterial coinfections in COVID-19: an underestimated adversary L Fattorini, R Creti, C Palma, A Pantosti Annali dell'Istituto superiore di sanita 56 (3), 359-364, 2020 | 102 | 2020 |
| The Mycobacterium tuberculosis Sigma Factor σB Is Required for Full Response to Cell Envelope Stress and Hypoxia In Vitro, but It Is Dispensable for In Vivo Growth PA Fontan, MI Voskuil, M Gomez, D Tan, M Pardini, R Manganelli, ... Journal of bacteriology 191 (18), 5628-5633, 2009 | 93 | 2009 |
| In vitro activity of protegrin-1 and beta-defensin-1, alone and in combination with isoniazid, against Mycobacterium tuberculosis L Fattorini, R Gennaro, M Zanetti, D Tan, L Brunori, F Giannoni, M Pardini, ... Peptides 25 (7), 1075-1077, 2004 | 93 | 2004 |
| Activities of drug combinations against Mycobacterium tuberculosis grown in aerobic and hypoxic acidic conditions G Piccaro, F Giannoni, P Filippini, A Mustazzolu, L Fattorini Antimicrobial agents and chemotherapy 57 (3), 1428-1433, 2013 | 91 | 2013 |
| Mycobacterium tuberculosis Diverts Alpha Interferon-Induced Monocyte Differentiation from Dendritic Cells into Immunoprivileged Macrophage-Like Host Cells S Mariotti, R Teloni, E Iona, L Fattorini, G Romagnoli, MC Gagliardi, ... Infection and immunity 72 (8), 4385-4392, 2004 | 88 | 2004 |
| Activities of Moxifloxacin Alone and in Combination with Other Antimicrobial Agents against Multidrug-Resistant Mycobacterium tuberculosis Infection in BALB/c Mice L Fattorini, D Tan, E Iona, M Mattei, F Giannoni, L Brunori, S Recchia, ... Antimicrobial Agents and Chemotherapy 47 (1), 360-362, 2003 | 87 | 2003 |
| Mycobacterium bovis Bacillus Calmette-Guérin infects DC-SIGN– dendritic cell and causes the inhibition of IL-12 and the enhancement of IL-10 production MC Gagliardi, R Teloni, F Giannoni, M Pardini, V Sargentini, L Brunori, ... Journal of leukocyte biology 78 (1), 106-113, 2005 | 86 | 2005 |
| Drug-resistant tuberculosis 2020: where we stand A Iacobino, L Fattorini, F Giannoni Applied Sciences 10 (6), 2153, 2020 | 82 | 2020 |
| Drug Resistance Evolution of a Mycobacterium tuberculosis Strain from a Noncompliant Patient F Meacci, G Orru, E Iona, F Giannoni, C Piersimoni, G Pozzi, L Fattorini, ... Journal of clinical microbiology 43 (7), 3114-3120, 2005 | 80 | 2005 |
| Activity of lipophilic and hydrophilic drugs against dormant and replicating Mycobacterium tuberculosis G Piccaro, G Poce, M Biava, F Giannoni, L Fattorini The journal of antibiotics 68 (11), 711-714, 2015 | 79 | 2015 |
| Evaluation of a New Line Probe Assay for Rapid Identification of gyrA Mutations in Mycobacterium tuberculosis F Giannoni, E Iona, F Sementilli, L Brunori, M Pardini, GB Migliori, ... Antimicrobial agents and chemotherapy 49 (7), 2928-2933, 2005 | 79 | 2005 |
